Osteoporosis

Osteoporosis News

• Drug-Releasing Microchip Passes First Test in Humans

  THURSDAY, February 16, 2012 (Health.com) — It sounds like something out of a sci-fi movie: A patient visits a doctor’s office and, after a brief surgical procedure, walks away with a microchip under her skin that delivers medication in precisely timed and measured doses. That scenario doesn’t seem so futuristic anymore. Researchers at the Massachusetts Institute [...]

• Heart Failure, Osteoporosis Go ‘Hand-in-Hand’: Researchers

  TUESDAY, Feb. 7 (HealthDay News) – Heart failure is linked to thinning of the bones and an increased risk of fractures, a new study indicates. The findings suggest that aggressive screening for osteoporosis may be important for heart failure patients, the researchers said. They looked at data from about 45,500 adults who underwent bone mineral density testing for [...]

• For Older Women, Year Following Hip Fracture Can Be Especially Deadly

  Women age 65 and older who fracture a hip are much more likely to die from any cause during the following year than they would be if they had avoided injury, a new study suggests.

• Bone Drug Fails to Prevent Breast Cancer Recurrence: Study

  By Kathleen DohenyHealthDay Reporter SUNDAY, Sept. 25 (HealthDay News) — The bone drug Zometa, once considered a promising weapon to reduce the risk of breast cancer recurrence, should not be used routinely in treatment of the disease, researchers say. In a new study of breast cancer patients, Zometa (zoledronic acid) did not increase disease-free survival overall, and [...]

• FDA Advisers Call for Revised Labels for Osteoporosis Drugs

  By Steven ReinbergHealthDay Reporter FRIDAY, Sept. 9 (HealthDay News) — U.S. Food and Drug Administration advisers recommended Friday that osteoporosis drugs such as Fosamax, Actonel, Boniva and Reclast come with revised labels, clarifying how long a patient should take a drug before potential health risks set in. The drugs, known as bisphosphonates, are taken to prevent [...]